Literature DB >> 3107116

A sensitive ELISA for von Willebrand factor (vWf:Ag).

J Ingerslev.   

Abstract

A sensitive and precise enzyme-linked immunosorbent assay for the measurement of the von Willebrand factor (new nomenclature:vWf:Ag, previous name: F VIII:RAg) of plasma and factor VIII concentrates was constructed using a microtitre plate based sandwich technique. The coating antibody extracted vWf:Ag from standard and test material. Bound fraction was detected by a F(ab')2 peroxidase conjugate of the same antibody as used for coating. The sensitivity limit of the assay was 0.004 IU/ml, at least 10 times lower than the electro-immunoassay (EIA) using the same antibody, and better than any previously reported polyclonal ELISA for vWf:Ag. Imprecision between runs was 5.1% (CV%) at the 0.50 IU/ml level. Plasma from 30 healthy people gave 1.02 +/- 0.25 IU/ml (mean +/- 1SD) in the ELISA assay and 0.99 +/- 0.30 IU/ml (mean +/- 1SD) using electro-immunoassay (EIA) with a correlation coefficient of 0.967. Two cases of homozygous recessive von Willebrand's disease revealed vWf:Ag values at or below buffer blank in all dilutions. In 18 patients with type I von Willebrand's disease, a correlation coefficient of 0.899 was found comparing ELISA and EIA. All patients with variant von Willebrand's disease tested exhibited complete dose-response congruity of patient plasma and pooled standard plasma calibrated against the 1st International Standard for Plasma F VIII. Factor VIII concentrates also behaved like normal plasma in the assay.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107116

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  11 in total

1.  Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

Authors:  Veronica H Flood; Pamela A Christopherson; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Daniel B Bellissimo; Rupa A Udani; Mahua Dasgupta; Raymond G Hoffmann; Margaret V Ragni; Amy D Shapiro; Jeanne M Lusher; Steven R Lentz; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Marilyn J Manco-Johnson; Ralph A Gruppo; Lisa N Boggio; Kate T Montgomery; Anne C Goodeve; Paula D James; David Lillicrap; Ian R Peake; Robert R Montgomery
Journal:  Blood       Date:  2016-02-09       Impact factor: 22.113

2.  Coagulation, inflammatory, and stress responses in a randomized comparison of open and laparoscopic repair of recurrent inguinal hernia.

Authors:  H B Rahr; J Bendix; P Ahlburg; J Gjedsted; P Funch-Jensen; E Tønnesen
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

3.  Rapid discrimination of the phenotypic variants of von Willebrand disease.

Authors:  Jonathan C Roberts; Patti A Morateck; Pamela A Christopherson; Ke Yan; Raymond G Hoffmann; Joan Cox Gill; Robert R Montgomery
Journal:  Blood       Date:  2016-02-25       Impact factor: 22.113

4.  Higher plasma levels of von Willebrand factor and C-reactive protein during a peritoneal dialysis regimen with less glucose and glucose degradation products.

Authors:  Caatje Y le Poole; Casper G Schalkwijk; Tom Teerlink; Rob M Valentijn; Piet M Ter Wee; Frans J van Ittersum
Journal:  Perit Dial Int       Date:  2013 Mar-Apr       Impact factor: 1.756

5.  Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy.

Authors:  T Jensen
Journal:  BMJ       Date:  1989-01-07

Review 6.  Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.

Authors:  Veronica H Flood
Journal:  Semin Thromb Hemost       Date:  2013-12-12       Impact factor: 4.180

7.  Quantitation of canine plasma von Willebrand factor antigen using a commercial enzyme-linked immunosorbent assay.

Authors:  I B Johnstone; S Crane
Journal:  Can J Vet Res       Date:  1991-01       Impact factor: 1.310

8.  Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes.

Authors:  T Deckert; H Yokoyama; E Mathiesen; B Rønn; T Jensen; B Feldt-Rasmussen; K Borch-Johnsen; J S Jensen
Journal:  BMJ       Date:  1996-04-06

9.  Procoagulant activity and intimal dysfunction in IDDM.

Authors:  B Myrup; P Rossing; T Jensen; J Gram; C Kluft; J Jespersen
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

10.  Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma).

Authors:  A Scheja; A Akesson; P Geborek; M Wildt; C B Wollheim; F A Wollheim; U M Vischer
Journal:  Arthritis Res       Date:  2001-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.